Efficacy and Safety of Methylene Blue in the Treatment of Severe Septic Shock

NARecruitingINTERVENTIONAL
Enrollment

488

Participants

Timeline

Start Date

June 22, 2024

Primary Completion Date

June 20, 2026

Study Completion Date

June 20, 2026

Conditions
Septic ShockMethylene BlueSepsis
Interventions
DRUG

Methylene Blue Intervention Group

In addition to standard treatment, patients will receive methylene blue intervention. The method is as follows: a loading dose of 2.5 mg/kg administered via micro-pump over 15 minutes, followed by a continuous infusion at a rate of 0.25 mg/kg/hour for 12 hours or until norepinephrine has been continuously discontinued for 4 hours, whichever comes first. If norepinephrine needs to be increased to 0.1 μg/kg/min before the 12-hour period ends, continue using methylene blue until the 12-hour infusion is completed.

DRUG

Normal Saline Control Group

In addition to standard treatment, patients will receive a placebo control with normal saline, administered for the same duration as the intervention group.

Trial Locations (1)

Unknown

RECRUITING

The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou

All Listed Sponsors
collaborator

Yuyao People's Hospital

OTHER

collaborator

Taizhou Enze Medical Center Group

OTHER

collaborator

NINGBO MEDICAL CENTER LIHUIIHOSPITAI

UNKNOWN

collaborator

People's Hospital of Guangxi Zhuang Autonomous Region

OTHER

collaborator

The second Nanning People's Hospital

UNKNOWN

collaborator

GUI LIN PEOPLE'S HOSPITAL

UNKNOWN

collaborator

Guangxi Hospital Division of The First Affiliated Hospital, Sun Yat-sen University

UNKNOWN

collaborator

The First People's Hospital of Huzhou

OTHER

collaborator

Hangzhou Yuhang District Second People's Hospital

UNKNOWN

collaborator

Wuming Hospital of Guangxi Medical University

UNKNOWN

lead

First Affiliated Hospital of Zhejiang University

OTHER